Wyeth Makes Its Case For Preemption To High Court

Law360, New York (May 28, 2008, 12:00 AM EDT) -- Wyeth has filed a brief with the U.S. Supreme Court, arguing that state-law product liability claims over one of its drugs are preempted by the Food and Drug Administration's approval of the drug in a case that could have far-reaching effects on product liability suits.

The case was originally filed in 2000 by Diana Levine, a professional musician who was given an intravenous push injection of its anti-nausea drug Phenergan when she went to the hospital for a headache.

She developed gangrene because of the injection...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.